Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in France
May 02, 2017 11:31 am UTC| Business
CRANBURY, N.J. and PARIS, May 02, 2017 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision medicine...
ICU Medical, Inc. Announces Time of First Quarter 2017 Earnings Call
May 02, 2017 11:31 am UTC| Business
SAN CLEMENTE, Calif., May 02, 2017 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today...
ICU Medical, Inc. Announces Time of First Quarter 2017 Earnings Call
May 02, 2017 11:31 am UTC| Business
SAN CLEMENTE, Calif., May 02, 2017 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today...
Spark Therapeutics to Host Conference Call on Tuesday, May 9 at 8:30 a.m. to Discuss Q1 2017 Results
May 02, 2017 11:31 am UTC| Business
PHILADELPHIA, May 02, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on Tuesday, May 9, 2017,...
Spark Therapeutics to Host Conference Call on Tuesday, May 9 at 8:30 a.m. to Discuss Q1 2017 Results
May 02, 2017 11:31 am UTC| Business
PHILADELPHIA, May 02, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on Tuesday, May 9, 2017,...
Neos Therapeutics to Host First Quarter 2017 Financial Results Conference Call on May 9, 2017
May 02, 2017 11:31 am UTC| Business
DALLAS and FORT WORTH, Texas, May 02, 2017 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its...
Neos Therapeutics to Host First Quarter 2017 Financial Results Conference Call on May 9, 2017
May 02, 2017 11:31 am UTC| Business
DALLAS and FORT WORTH, Texas, May 02, 2017 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its...
Trump Floats Greenland Framework, Bets Big on ‘Mission 500’ With India